Company / Current Assets per Share
VYNE Therapeutics Inc. Current Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$4.35
FY2025
5-year range
$1.46 / $29.71
FY2021-FY2025
Trend
-4.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has fluctuated over the past 8 years, ranging from $1.46 in FY2021 to $29.71 in FY2023.
Based on SEC 10-K filings.
4.35 in FY2025 with a 5-year CAGR of -14.6%.
Declined from $29.71 to $4.35 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -30.3%
- 5-Year CAGR
- -14.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share decreased 4.9% year-over-year.
- Peak current assets per share was recorded in FY2023.
- Lowest current assets per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.35 | -4.9% |
| FY2024 | $4.57 | -84.6% |
| FY2023 | $29.71 | +131.1% |
| FY2022 | $12.86 | +779.3% |
| FY2021 | $1.46 | -84.7% |
| FY2020 | $9.57 | +183.8% |
| FY2019 | $3.37 | -87.2% |
| FY2018 | $26.33 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026